May 2, 2025
June 9, 2025
This week’s newsletter included:
- Edwards TAVR Receives FDA Approval
- MedVenture Health Re-brands to Wasatch Health
- Foreign Trade Zone Provides Possible Deferral of Tariffs
- Rep. Burgess Owens Tours Seek Labs
- Utah Business Recognizes Brooke Clark for HR Achievement 2025
- U of U Health: Our Research Matters
- Fluidx’s GPXembolic Clinical Trial Publication Awarded as People’s Choice
- BioUtah’s Biosphere Advertising Prospectus
- Mental Health Medication Side Effects Concerns Remain, According to GeneSight Mental Health Monitor
- Thermo Fisher Scientific Leverages Integrated Solutions to Accelerate the Development of Biological Therapeutics
- Davis Journal: Life-changing Moment Led Inventor to Revolutionize MRI Safety
- U of U Spin-out Bioparin Secures STTR Grant to Prevent Future Health Crisis
- Nusano Names Rachel Culberston VP of Supply Chain
- Researcher Bruce Edgar Elected to National Academy of Sciences
- Join the Nelson Labs 40th Anniversary Golf Tournament
- 2025 Utah Business Fast 50 Registration
- Utah Business: Nominations for Most Influential Women open
- Utah Business: Nominations for Innovation Awards Open
Featured BioUtah New Member: The nimbl network
Recent News
- BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
- Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform
- Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
- Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
- GE HealthCare’s Economic Impact Across Utah
- RefloDx Wins Trans Atlantic Angel Grand Prize
